2022
DOI: 10.1097/dcr.0000000000002323
|View full text |Cite
|
Sign up to set email alerts
|

The American Society of Colon and Rectal Surgeons Clinical Practice Guidelines for the Management of Colon Cancer

Abstract: Earn Continuing Education (CME) credit online at cme.lww.com. This activity has been approved for AMA PRA Category 1 credit. TM Funding/Support: None reported.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
104
0
4

Year Published

2022
2022
2024
2024

Publication Types

Select...
8
1

Relationship

1
8

Authors

Journals

citations
Cited by 139 publications
(126 citation statements)
references
References 336 publications
(481 reference statements)
0
104
0
4
Order By: Relevance
“…Adjuvant chemotherapy in the presence of locally advanced rectal cancer might not change the prognosis as there has been inconsistency in its benefits. Education and increasing the awareness of parents and health workers in primary care or pediatricians play a major role in dealing with this syndrome [ 1 , 12 , 14 - 16 ].…”
Section: Discussionmentioning
confidence: 99%
“…Adjuvant chemotherapy in the presence of locally advanced rectal cancer might not change the prognosis as there has been inconsistency in its benefits. Education and increasing the awareness of parents and health workers in primary care or pediatricians play a major role in dealing with this syndrome [ 1 , 12 , 14 - 16 ].…”
Section: Discussionmentioning
confidence: 99%
“…10 The 2B evidence grade and the wording of the recommendation should be reconsidered. The only RCT evidence suggests no major benefit and the observational evidence is not “exceptionally strong.” 2…”
Section: To the Editor—mentioning
confidence: 99%
“…We appreciated seeing the randomized controlled trial (RCT), Pulmonary Metastasectomy in Colorectal Cancer (PulMICC), 1 cited in the Guidelines for the Management of Colon Cancer. 2 PulMiCC was accurately quoted as finding that patients randomly assigned to have metastasectomy had shorter median survival time (3.5 [95% CI, 3.1–6.6] years) compared with controls (3.8 [3.5–4.6] years). Yet the guidance is that “resection of the lung lesions should be considered because it may prolong survival.”…”
Section: To the Editor—mentioning
confidence: 99%
“…Although the evidence on this subject is limited and with conflicting results, we believe we have presented that evidence fairly. We cited 3 large observational studies from high-impact journals citing positive results with pulmonary metastectomy and balanced this discussion by showing the negative results of the Pulmonary Metastasectomy in Colorectal Cancer study, stating that “nonsurgical treatment should also be considered.” 1–5 Williams et al cite the limitations of the Pulmonary Metastasectomy in Colorectal Cancer trial in their editorial. It is important to note that there is no large, randomized trial with well-matched patient cohorts on this topic indicating some persistent clinical equipoise.…”
Section: To the Editor—mentioning
confidence: 99%